Long acting insulin:
**Core Concept**
Long-acting insulin is a type of basal insulin that provides a steady release of glucose-lowering activity over a prolonged period, typically 24 hours or more. It is designed to mimic the body's natural basal insulin production, providing a consistent background level of insulin to control fasting glucose levels.
**Why the Correct Answer is Right**
Long-acting insulins, such as glargine or detemir, have a unique pharmacokinetic profile that allows for a gradual and sustained release of insulin. This is achieved through a combination of slow absorption and a high degree of protein binding, which slows down the elimination of the insulin from the body. As a result, long-acting insulins provide a smooth and consistent level of insulin activity throughout the day, making them ideal for controlling fasting glucose levels in patients with type 1 or type 2 diabetes.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a type of insulin that is known for its long-acting properties.
**Option B:** This option is incorrect because it is a type of rapid-acting insulin, which has a short duration of action and is not suitable for basal insulin therapy.
**Option C:** This option is incorrect because it is not a type of insulin that is commonly used for basal insulin therapy.
**Clinical Pearl / High-Yield Fact**
When choosing a long-acting insulin, it's essential to consider the patient's individual needs and preferences, as well as their specific diabetes regimen. For example, patients who require more flexibility in their dosing schedule may prefer a rapid-acting insulin, while those who require more consistent glucose control may benefit from a long-acting insulin.
**Correct Answer:** Glargine.